Impact of resistance on therapeutic design: a Moran model of cancer growth
From MaRDI portal
Publication:6124362
Recommendations
- Evolution of resistance to anti-cancer therapy during general dosing schedules
- Dosage optimization for reducing tumor burden using a phenotype-structured population model with a drug-resistance continuum
- Spatio-genetic and phenotypic modelling elucidates resistance and re-sensitisation to treatment in heterogeneous melanoma
- Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions
- A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence
Cites work
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- An evolutionary model of tumor cell kinetics and the emergence of molecular heterogeneity driving Gompertzian growth
- Evolutionary game dynamics in finite populations
- Introduction to stochastic models in biology
- Mathematical oncology: using mathematics to enable cancer discoveries
- Spatial stochastic models for cancer initiation and progression
- Waiting times in a branching process model of colorectal cancer initiation
Cited in
(3)- Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma
- Parameter estimation from single patient, single time-point sequencing data of recurrent tumors
- Dosage optimization for reducing tumor burden using a phenotype-structured population model with a drug-resistance continuum
This page was built for publication: Impact of resistance on therapeutic design: a Moran model of cancer growth
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6124362)
